| 
       From the early smallpox virus to SARS-CoV-2, every
      pandemic of viral infections poses a severe threat to human health[1][2].
      Due to the virus’s mutability, infectivity, and drug resistance, vaccines
      and antiviral drugs targeting the virus need to be continuously improved[3].
      So far, many viral diseases still lack effective therapeutic drugs, and
      natural products with diverse chemical structures and extensive
      pharmacological activities, making them essential source for discovery of
      new antiviral drugs[4].  
       | 
      
     
     | 
    
   
    | 
     Natural Product Antiviral Advantages  
     | 
    
   
    | 
     Natural products have more diverse ways of acting than
    synthetic compounds acting on a specific target during viral infection.
    Taking anti-SARS CoV-2 as an example, in addition to targeting some key
    proteins (3CLpro, ACE2, FURIN and RdRp), natural products also have
    immunomodulatory, anti-inflammatory and anti liver failure activities,
    which can regulate immune balance and reduce infection symptoms during the
    treatment of COVID-19[5].  
     | 
    
   
    | 
       
     | 
    
   
    | 
     Figure 1. Effect of natural products on
    SARS-CoV-2[5].  
     | 
    
   
    | 
     Application of Natural Antiviral Products  
     | 
    
   
    | 
     Many classic natural products have antiviral activity. For
    example, stilbene compounds (molecules with a styrene backbone and their
    polymers) represented by Resveratrol have extensive antiviral activity.
    Stilbene compounds can exist as monomers or polymers with a vast amount,
    providing a material basis for discovering new antiviral drugs[6].
     
     | 
    
   
    | 
     MCE Provides a
    Variety of Natural Antiviral Products  
     | 
    
   
    
    
     
      | 
       Structural 
      Classification  
       | 
      
       Product Name 
       | 
      
       Function 
       | 
      
     
      | 
       Stilbene
       
       | 
      
       Resveratrol  
       | 
      
       Specific SIRT1 activator, PXR inhibitor,  
      Nrf2 activator; 
      Other targets: mTOR, JAK, ß-amyloid,  
      Adenylyl cyclase, IKKß, DNA polymerase; 
      Anti-viral, anti-cancer, anti-inflammatory, antioxidant, cardioprotective
      activities.  
       | 
      
     
      | 
       Pterostilbene  
       | 
      
       SARS-COV-2 replication inhibitor; 
      Suppress ROS generation; 
      Anti-viral, anti-cancer, antioxidant, anti-inflammatory, and
      anti-diabetic effects.  
       | 
      
     
      | 
       Piceatannol  
       | 
      
       Syk inhibitor; 
      Induces apoptosis and autophagy; 
      Anti-cancer, anti-inflammatory, and anti-viral activities.  
       | 
      
     
      | 
       Oxyresveratrol  
       | 
      
       Non-competitive tyrosinase inhibitor,  
      antioxidant, free radical scavenger; 
      Antiviral effcts, such as HSV-1, HSV-2, and varicella-zoster virus.  
       | 
      
     
      | 
       Alkaloid  
       | 
      
       Cepharanthine  
       | 
      
       SARS-CoV-2 inhibitor, Cytochrome P450 inhibitor; 
      Antiviral, anticancer, anti-inflammatory, and analgesic effects.  
       | 
      
     
      | 
       Flavone  
       | 
      
       Glabrone  
       | 
      
       Specific UGT1A9 probe substrate; 
      Inhibits influenza virus.  
       | 
      
     
      | 
       Benzene Quinones  
       | 
      
       Geldanamycin  
       | 
      
       Hsp90 inhibitor, H5N1 inhibitor; 
      Antiviral and anticancer activities.  
       | 
      
     
      | 
       Lignan  
       | 
      
       Clemastanin B  
       | 
      
       Viral proliferation inhibitor; 
      Targets viral endocytosis, uncoating,  
      or ribonucleoprotein (RNP) export from the  
      nucleus.  
       | 
      
     
     | 
    
   
    
    
     
      | 
       References:   
       | 
      
     
      | 
       [1] Biomed Res Int. 2021 Dec 8; 2021:7872406. 
      [2] Eur J Med Chem. 2020 Dec 1; 207: 112790.  
      [3] Environ Sci Pollut Res Int. 2022 Jun; 29(28): 42404-42432. 
      [4] Eur J Med Chem. 2023 Nov 15; 260: 115726.  
      [5] Phytother Res. 2022 Oct; 36(10): 3833-3858.  
       | 
      
     
     | 
    
   
    | 
       
     | 
    
   
   |